Ligand validation:2ZRX

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 2ZRX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ZRX_FMN_B_669	70%	36%	0.161	0.98	1.08	1.43	2	10	1	0	100%	1
2ZRX_FMN_A_669	70%	39%	0.153	0.971	1.03	1.33	2	7	1	0	100%	1
2ZRX_FMN_C_669	69%	38%	0.15	0.966	1.04	1.36	1	7	1	0	100%	1
2ZRX_FMN_D_669	62%	37%	0.176	0.969	1.03	1.45	2	8	0	0	100%	1
2ZRW_FMN_C_669	93%	39%	0.091	0.984	0.97	1.42	1	6	0	0	100%	1
2ZRU_FMN_C_669	85%	42%	0.115	0.982	1	1.24	2	5	0	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.